NCT05567692View on ClinicalTrials.gov

Subjects With T2D or at Risk of T2D Cohort Follow-up

Active, not recruitingOBSERVATIONAL
Enrollment

837

Participants

Timeline

Start Date

February 10, 2023

Primary Completion Date

October 1, 2032

Study Completion Date

October 1, 2032

Conditions
Diabetes Mellitus, Type 2
Interventions
DIAGNOSTIC_TEST

OGTT

Oral Glucose Tolerance Test

OTHER

HbA1c

HbA1c measurement

OTHER

Questionnaire

Follow-up questionnaire

Trial Locations (1)

91058

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète, Évry

All Listed Sponsors
collaborator

Institut Pasteur de Lille

OTHER

lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT05567692 - Subjects With T2D or at Risk of T2D Cohort Follow-up | Biotech Hunter | Biotech Hunter